{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:49:23Z","timestamp":1787507363175,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,21]]},"DOI":"10.7759\/cureus.99760","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T11:21:23Z","timestamp":1766316083000},"source":"Crossref","is-referenced-by-count":1,"title":["Autoimmune Pulmonary Alveolar Proteinosis Triggered by Salazosulfapyridine in a Patient With Rheumatoid Arthritis: A Case Report"],"prefix":"10.7759","author":[{"given":"Tomoyuki","family":"Ikeuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Touge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Burioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-40","article-title":"Assessment and management of pulmonary alveolar proteinosis in a reference center","volume":"8","author":"Campo I","year":"2013","unstructured":"Campo I, Mariani F, Rodi G, et al.. Assessment and management of pulmonary alveolar proteinosis in a reference center. Orphanet J Rare Dis. 2013, 8:40. 10.1186\/1750-1172-8-40","journal-title":"Orphanet J Rare Dis"},{"key":"ref2","article-title":"Targeting GM-CSF in rheumatoid arthritis","volume":"34","author":"Avci AB","year":"2016","unstructured":"Avci AB, Feist E, Burmester GR. Targeting GM-CSF in rheumatoid arthritis. Clin Exp Rheumatol. 2016, 34:S39-44.","journal-title":"Clin Exp Rheumatol"},{"key":"ref3","article-title":"A case of autoimmune pulmonary alveolar proteinosis complicated by rheumatoid arthritis","volume":"9","author":"Hashimoto M","year":"2020","unstructured":"Hashimoto M, Suga K, Hatakeyama T, Horibe R, Nishiyama K. A case of autoimmune pulmonary alveolar proteinosis complicated by rheumatoid arthritis. Annals of the Japanese Respiratory Society. 2020, 9:477-81.","journal-title":"Annals of the Japanese Respiratory Society"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816216","article-title":"Inhaled GM-CSF for pulmonary alveolar proteinosis","volume":"381","author":"Tazawa R","year":"2019","unstructured":"Tazawa R, Ueda T, Abe M, et al.. Inhaled GM-CSF for pulmonary alveolar proteinosis. N Engl J Med. 2019, 381:923-32. 10.1056\/NEJMoa1816216","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2006.00905.x","article-title":"Pulmonary alveolar proteinosis associated with a disease-modifying antirheumatoid arthritis drug","volume":"11","author":"Wardwell NR Jr","year":"2006","unstructured":"Wardwell NR Jr, Miller R, Ware LB. Pulmonary alveolar proteinosis associated with a disease-modifying antirheumatoid arthritis drug. Respirology. 2006, 11:663-5. 10.1111\/j.1440-1843.2006.00905.x","journal-title":"Respirology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2017.02.002","article-title":"Two cases of autoimmune pulmonary alveolar proteinosis with rheumatoid arthritis","volume":"66","author":"Ito S","year":"2017","unstructured":"Ito S, Wakahara K, Kojima T, Takahashi N, Nishiwaki K, Yamaguchi E, Hasegawa Y. Two cases of autoimmune pulmonary alveolar proteinosis with rheumatoid arthritis. Allergol Int. 2017, 66:507-9. 10.1016\/j.alit.2017.02.002","journal-title":"Allergol Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.290.6481.1535","article-title":"Which component of sulphasalazine is active in rheumatoid arthritis?","volume":"290","author":"Pullar T","year":"1985","unstructured":"Pullar T, Hunter JA, Capell HA. Which component of sulphasalazine is active in rheumatoid arthritis?. Br Med J (Clin Res Ed). 1985, 290:1535-8. 10.1136\/bmj.290.6481.1535","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s1567-5769(01)00186-2","article-title":"Regulation of human B cell function by sulfasalazine and its metabolites","volume":"2","author":"Hirohata S","year":"2002","unstructured":"Hirohata S, Ohshima N, Yanagida T, Aramaki K. Regulation of human B cell function by sulfasalazine and its metabolites. Int Immunopharmacol. 2002, 2:631-40. 10.1016\/s1567-5769(01)00186-2","journal-title":"Int Immunopharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1006\/exmp.2002.2460","article-title":"The effect of sulfasalazine on rheumatoid arthritic synovial tissue chemokine production","volume":"73","author":"Volin MV","year":"2002","unstructured":"Volin MV, Campbell PL, Connors MA, Woodruff DC, Koch AE. The effect of sulfasalazine on rheumatoid arthritic synovial tissue chemokine production. Exp Mol Pathol. 2002, 73:84-92. 10.1006\/exmp.2002.2460","journal-title":"Exp Mol Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI992","article-title":"Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B","volume":"101","author":"Wahl C","year":"1998","unstructured":"Wahl C, Liptay S, Adler G, Schmid RM. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest. 1998, 101:1163-74. 10.1172\/JCI992","journal-title":"J Clin Invest"},{"key":"ref11","article-title":"Sulfasalazine induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor","volume":"19","author":"Kuipers EJ","year":"1992","unstructured":"Kuipers EJ, Vellenga E, de Wolf JT, Hazenberg BP. Sulfasalazine induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor. J Rheumatol. 1992, 19:621-2.","journal-title":"J Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198308060-00002","article-title":"Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics","volume":"8","author":"Wallis WJ","year":"1983","unstructured":"Wallis WJ, Simkin PA. Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics. Clin Pharmacokinet. 1983, 8:496-522. 10.2165\/00003088-198308060-00002","journal-title":"Clin Pharmacokinet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/BF00541351","article-title":"Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis","volume":"5","author":"Farr M","year":"1985","unstructured":"Farr M, Brodrick A, Bacon PA. Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis. Rheumatol Int. 1985, 5:247-51. 10.1007\/BF00541351","journal-title":"Rheumatol Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.glmedi.2024.100118","article-title":"An autopsy presentation of spontaneous splenic rupture in chronic myeloid leukemia: a rare case report","volume":"3","author":"Kanani J","year":"2024","unstructured":"Kanani J, Sheikh MI. An autopsy presentation of spontaneous splenic rupture in chronic myeloid leukemia: a rare case report. J Med Surg Public Health. 2024, 3:100118. 10.1016\/j.glmedi.2024.100118","journal-title":"J Med Surg Public Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/433069-autoimmune-pulmonary-alveolar-proteinosis-triggered-by-salazosulfapyridine-in-a-patient-with-rheumatoid-arthritis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T11:21:24Z","timestamp":1766316084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/433069-autoimmune-pulmonary-alveolar-proteinosis-triggered-by-salazosulfapyridine-in-a-patient-with-rheumatoid-arthritis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.99760","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,21]]}}}